243 related articles for article (PubMed ID: 19091461)
21. Apoptotic impact of alpha1-blockers on prostate cancer growth: a myth or an inviting reality?
Tahmatzopoulos A; Kyprianou N
Prostate; 2004 Apr; 59(1):91-100. PubMed ID: 14991869
[TBL] [Abstract][Full Text] [Related]
22. Apoptosis induction by quinazoline-derived alpha1-blockers in prostate cancer cells: biomolecular implications and clinical relevance.
Alberti C
Eur Rev Med Pharmacol Sci; 2007; 11(1):59-64. PubMed ID: 17405349
[TBL] [Abstract][Full Text] [Related]
23. 2-Methoxyestradiol induces G2/M arrest and apoptosis in prostate cancer.
Qadan LR; Perez-Stable CM; Anderson C; D'Ippolito G; Herron A; Howard GA; Roos BA
Biochem Biophys Res Commun; 2001 Aug; 285(5):1259-66. PubMed ID: 11478793
[TBL] [Abstract][Full Text] [Related]
24. Raloxifene, a mixed estrogen agonist/antagonist, induces apoptosis in androgen-independent human prostate cancer cell lines.
Kim IY; Kim BC; Seong DH; Lee DK; Seo JM; Hong YJ; Kim HT; Morton RA; Kim SJ
Cancer Res; 2002 Sep; 62(18):5365-9. PubMed ID: 12235008
[TBL] [Abstract][Full Text] [Related]
25. Taxol synergizes with antioxidants in inhibiting hormal refractory prostate cancer cell growth.
Ping SY; Hour TC; Lin SR; Yu DS
Urol Oncol; 2010; 28(2):170-9. PubMed ID: 18818108
[TBL] [Abstract][Full Text] [Related]
26. Epidermal growth factor-induced neuroendocrine differentiation and apoptotic resistance of androgen-independent human prostate cancer cells.
Humez S; Monet M; Legrand G; Lepage G; Delcourt P; Prevarskaya N
Endocr Relat Cancer; 2006 Mar; 13(1):181-95. PubMed ID: 16601287
[TBL] [Abstract][Full Text] [Related]
27. Pro-apoptotic effect and cytotoxicity of genistein and genistin in human ovarian cancer SK-OV-3 cells.
Choi EJ; Kim T; Lee MS
Life Sci; 2007 Mar; 80(15):1403-8. PubMed ID: 17291540
[TBL] [Abstract][Full Text] [Related]
28. Genistein-induced upregulation of p21WAF1, downregulation of cyclin B, and induction of apoptosis in prostate cancer cells.
Davis JN; Singh B; Bhuiyan M; Sarkar FH
Nutr Cancer; 1998; 32(3):123-31. PubMed ID: 10050261
[TBL] [Abstract][Full Text] [Related]
29. Targeting cancer cell metabolism: the combination of metformin and 2-deoxyglucose induces p53-dependent apoptosis in prostate cancer cells.
Ben Sahra I; Laurent K; Giuliano S; Larbret F; Ponzio G; Gounon P; Le Marchand-Brustel Y; Giorgetti-Peraldi S; Cormont M; Bertolotto C; Deckert M; Auberger P; Tanti JF; Bost F
Cancer Res; 2010 Mar; 70(6):2465-75. PubMed ID: 20215500
[TBL] [Abstract][Full Text] [Related]
30. [Effect of nitric oxide donor and alpha1-receptor antagonist on proliferation/apoptosis of hyperplastic prostatic stromal cells in vitro].
Deng CH; Chen HR; Qiu SP; Liu JZ; Zheng KL; Mei H
Zhonghua Wai Ke Za Zhi; 2004 Feb; 42(4):201-4. PubMed ID: 15062034
[TBL] [Abstract][Full Text] [Related]
31. Expression of Nkx3.1 enhances 17beta-estradiol anti-tumor action in PC3 human prostate cancer cells.
Wang P; Liu B; Luo JD; Zhang ZG; Ma Q; Chen ZD
Asian J Androl; 2007 May; 9(3):353-60. PubMed ID: 17486276
[TBL] [Abstract][Full Text] [Related]
32. Genistein potentiates the radiation effect on prostate carcinoma cells.
Hillman GG; Forman JD; Kucuk O; Yudelev M; Maughan RL; Rubio J; Layer A; Tekyi-Mensah S; Abrams J; Sarkar FH
Clin Cancer Res; 2001 Feb; 7(2):382-90. PubMed ID: 11234894
[TBL] [Abstract][Full Text] [Related]
33. Inactivation of nuclear factor kappaB by soy isoflavone genistein contributes to increased apoptosis induced by chemotherapeutic agents in human cancer cells.
Li Y; Ahmed F; Ali S; Philip PA; Kucuk O; Sarkar FH
Cancer Res; 2005 Aug; 65(15):6934-42. PubMed ID: 16061678
[TBL] [Abstract][Full Text] [Related]
34. Tranilast inhibits hormone refractory prostate cancer cell proliferation and suppresses transforming growth factor beta1-associated osteoblastic changes.
Izumi K; Mizokami A; Li YQ; Narimoto K; Sugimoto K; Kadono Y; Kitagawa Y; Konaka H; Koh E; Keller ET; Namiki M
Prostate; 2009 Aug; 69(11):1222-34. PubMed ID: 19434660
[TBL] [Abstract][Full Text] [Related]
35. Effect of leuprolide and cetrorelix on cell growth, apoptosis, and GnRH receptor expression in primary cell cultures from human prostate carcinoma.
Castellón E; Clementi M; Hitschfeld C; Sánchez C; Benítez D; Sáenz L; Contreras H; Huidobro C
Cancer Invest; 2006; 24(3):261-8. PubMed ID: 16809153
[TBL] [Abstract][Full Text] [Related]
36. Doxazosin and terazosin suppress prostate growth by inducing apoptosis: clinical significance.
Kyprianou N
J Urol; 2003 Apr; 169(4):1520-5. PubMed ID: 12629407
[TBL] [Abstract][Full Text] [Related]
37. Piperazine-designed alpha 1A/alpha 1D-adrenoceptor blocker KMUP-1 and doxazosin provide down-regulation of androgen receptor and PSA in prostatic LNCaP cells growth and specifically in xenografts.
Liu CM; Lo YC; Tai MH; Wu BN; Wu WJ; Chou YH; Chai CY; Huang CH; Chen IJ
Prostate; 2009 May; 69(6):610-23. PubMed ID: 19143029
[TBL] [Abstract][Full Text] [Related]
38. Sodium caffeate induces endothelial cell apoptosis and inhibits VEGF expression in cancer cells.
Xu F; Ou-Yang ZG; Zhang SH; Song DQ; Shao RG; Zhen YS
Yao Xue Xue Bao; 2006 Jun; 41(6):572-6. PubMed ID: 16927835
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of human experimental prostate cancers by a targeted cytotoxic luteinizing hormone-releasing hormone analog AN-207.
Stangelberger A; Schally AV; Nagy A; Szepeshazi K; Kanashiro CA; Halmos G
Prostate; 2006 Feb; 66(2):200-10. PubMed ID: 16173040
[TBL] [Abstract][Full Text] [Related]
40. The combined treatment of 1,25-dihydroxyvitamin D3 and a non-steroid anti-inflammatory drug is highly effective in suppressing prostate cancer cell line (LNCaP) growth.
Gavrilov V; Steiner M; Shany S
Anticancer Res; 2005; 25(5):3425-9. PubMed ID: 16101159
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
